$OXIS Biotech, Inc. Licenses Worldwide Rights to Cancer Therapy with Positive FDA Phase I Study Results

Oxis Biotech, a wholly-owned subsidiary of Oxis International, Inc. (OTCQB: OXIS) is…

$OXIS Amended Option Agreement Announced

Oxis Biotech Executes Amended Option Agreement With the University of Pittsburgh TAMPA,…

$OXIS Update Provided by @WolfOfWeedST

OXIS has been a topic of conversation as well as a very…

Seeing Into the Future…And Boy Is It Pretty

You know the age old question, “If you had a super power…